
Aasritha Thippavajjala
PharmD
Aasritha Thippavajjala is a pharm D student and aspiring medical writer with medical writing, clinical training experience and a strong interest in clinical research and patient safety She has hands-on exposure to clinical pharmacy activities including medication profile assessment, clinical case review, identification of potential drug-related problems, ADR awareness, patient counselling, and clinical documentation. She has also gained experience in medical literature review, evidence synthesis, and scientific communication through her published review article on digital twin-based patient simulation and her poster presentation at the 74th Indian Pharmaceutical Congress. Certified in ICH Good Clinical Practice (E6(R3)) and Scientific Writing in Health Research, she is passionate about applying her clinical knowledge and research skills to medical writing,clinical research and contributing to accurate, evidence-based healthcare.
About Aasritha
Aasritha Thippavajjala (PharmD) is a writer at Pharmacally, with 41 published articles, each checked against primary sources by our editorial team.
Articles by Aasritha Thippavajjala
Clinical TrialsRetatrutide Delivers 20.9% Mean Weight Loss Against Semaglutide
Clinical TrialsPfizer Reports Positive PFS Results for ELREXFIO in RRMM Trial
Health TidingsLilly Reports Promising Results for Olomorasib in Lung Cancer
Health TidingsIdorsia’s Daridorexant Shows Sleep Benefits in Children With Insomnia
Clinical TrialsBMS’s Zola-cel Shows Early Promise in Relapsing and Progressive MS
Health TidingsBioNTech to Test Pumitamig With Trodelvy in Advanced TNBC
Health TidingsKyverna Reports 49% Walking Improvement With Miv-cel at One Year
Clinical TrialsVeradermics Reports Higher Hair Growth With VDPHL01 in Phase 3
New Drug ApprovalUCB Wins FDA Approval for ZILBRYSQ Autoinjector With 99.8% Dose Delivery
A. Musharaf Mohammad
Aabha Dey